Results 11 to 20 of about 28,034 (103)

Truncal acne: Bridging research gaps and enhancing clinical understanding

Journal of dermatologic science and cosmetic technology
Background: Acne affects individuals across all ages and ethnic groups. Truncal acne has received limited attention, and its mechanisms and characteristics remain poorly understood.
Hong Meng
exaly   +4 more sources

Truncal Acne: An Overview [PDF]

Journal of Clinical Medicine, 2022
Acne is a relatively common disease of the pilosebaceous units. Many aspects of facial acne have been studied. However, there is limited evidence regarding truncal acne.
Yu Ri Woo
exaly   +3 more sources

Evaluation of Psychological Wellbeing and Social Impact of Combined Facial and Truncal Acne: a Multi-national, Mixed-Methods Study [PDF]

Dermatology and Therapy, 2022
International audienceIntroduction: Half of the individuals with facial acne develop truncal acne, but the impact of combined facial and truncal acne (CA) on patients' quality of life is poorly researched.Methods: A 60-min interview of 30 participants ...
Stefan Beissert, Jerry Tan
exaly   +3 more sources

Prospective Evaluation of a Topical Botanical Skin Care Regimen on Mild to Moderate Facial and Truncal Acne and Mood [PDF]

Journal of Clinical Medicine, 2023
Acne vulgaris is a common inflammatory condition that can be associated with profound psychosocial impacts. Conventional treatment includes topical retinoids, benzoyl peroxide, and antimicrobials, and some may cause irritation and skin dryness. In this 8-
Yvonne Nong, Waqas Burney
exaly   +4 more sources

Bridging Gaps in Malaysian Acne Vulgaris Guidelines: Advisory Statements on Trifarotene for Facial and Truncal Acne. [PDF]

J Cosmet Dermatol
ABSTRACT Background Trifarotene, a fourth‐generation topical retinoid, offers a novel therapeutic option for facial and truncal acne. However, its role was only briefly addressed in Malaysia's 2022 Clinical Practice Guidelines (CPGs) due to its unavailability at the time.
Mohd Affandi A, Ch'ng PWB, Teoh BTY, Yap EWY, Ch'ng CC, Foo SH, How KN, Kwan Z, Tang JJ, Tan WC, Kon K, Poh WT.   +11 more
europepmc   +2 more sources

Advances in the Application of Chemical Peels in the Treatment of Pigmentary Skin Disorders [PDF]

J Cosmet Dermatol
ABSTRACT Background Pigmentary disorders, including melasma, postinflammatory hyperpigmentation (PIH), solar lentigines, Riehl's melanosis, and periorbital hyperpigmentation, are common concerns in cosmetic dermatology, particularly in patients with skin of color.
Li Y, Xiang W.
europepmc   +2 more sources

Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate-to-Severe Acne. [PDF]

J Cosmet Dermatol
ABSTRACT Background Acne vulgaris is a common inflammatory skin disorder with significant psychosocial impact. While isotretinoin remains the gold standard for moderate‐to‐severe cases, its adverse effects and teratogenicity underscore the need for alternative systemic therapies.
Tommasino N, Annunziata MC, Potestio L, Napolitano M.   +3 more
europepmc   +2 more sources

A Possible Role of Mycobiome in the Pathophysiology of Acne: Structured Narrative Review and Perspectives. [PDF]

Exp Dermatol
ABSTRACT Acne vulgaris pathogenesis involves complex interactions between sebum hypersecretion, follicular hyperkeratinisation, microbial colonisation and inflammatory cascades. While the bacterial microbiome has been extensively studied, the role of the skin mycobiome, particularly lipophilic Malassezia species, remains less clearly defined in acne ...
Kerob D, Salah S, Dal Belo SE, Odeimi J, Clavaud C, Demessant-Flavigny A.   +5 more
europepmc   +2 more sources

Epidemiology and Treatment Challenges of Acne, With Insights Into the Role of Dermocosmetics: An Expert Consensus From India—A Modified Delphi Method [PDF]

J Cosmet Dermatol
ABSTRACT Background Acne vulgaris is a common skin condition that typically begins in adolescence but can often persist in adulthood, contributing to significant physical and psychosocial burden. Despite the availability of multiple treatment options, challenges such as poor adherence, treatment‐related side effects, and post‐inflammatory ...
Sachdev M, Madnani N, Kohli M, Lahiri K, Tiwari A, Sarangi K, Kandhari R, Damisetty R, Bhat R, Kerob D, Trasi‐Nerurkar S.   +10 more
europepmc   +2 more sources

Update of the EuroGuiDerm evidence-based guideline for the treatment of acne-Short version. [PDF]

J Eur Acad Dermatol Venereol
The 2025 EuroGuiDerm guideline update provides evidence‐based recommendations for acne management, addressing systemic antibiotics, systemic isotretinoin, hormonal therapies including spironolactone and contraceptives, and new topical agents. Key considerations include treatment duration, safety, pregnancy‐specific guidance and minimizing antibiotic ...
Nast A, Al Wattar BH, Beylot Barry M, Brüggemann H, Bukvić Mokos Z, Caruana DM, Degitz K, Dessinioti C, Dréno B, Driessen RJB, Gollnick H, Hædersdal M, Katoulis A, Läuchli S, Lambert J, Layton AM, Micali G, Ochsendorf FR, Sathyapalan T, Stangeland KZ, Thomsen SF, Töröcsik D, Pennitz A.   +22 more
europepmc   +2 more sources